Wells Fargo upgraded Johnson & Johnson to Overweight from Equal Weight with a price target of $212, up from $170.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on JNJ:
- Dentsply Sirona appoints Denti as Chief Commercial Officer
- Nanobiotix presents data from JNJ-1900 dose escalation, expansion study cohorts
- Nike reports Q1 beat, U.S. takes 5% stake in Lithium Americas: Morning Buzz
- Trump Trade: White House announces drug pricing deal with Pfizer
- Trump outlines plan for next round of Medicare drug price talks, Bloomberg says